PHARMACOLOGY OF MITOXANTRONE IN CANCER-PATIENTS

被引：62

作者：

SAVARAJ, N

LU, K

MANUEL, V

LOO, TL

机构：

来源：

CANCER CHEMOTHERAPY AND PHARMACOLOGY | 1982年 / 8卷 / 01期

关键词：

D O I：

10.1007/BF00292881

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：113 / 117

页数：5

共 12 条

[1] EVALUATION OF BINDING OF SOME SUBSTITUTED ANTHRAQUINONES AND NAPHTHACENEQUINONES TO DNA [J].

DOUBLE, JC ;

BROWN, JR .

JOURNAL OF PHARMACY AND PHARMACOLOGY, 1976, 28 (02) :166-169

[2] INTERACTION OF AMINOALKYLAMINOANTHRAQUINONES WITH DEOXYRIBONUCLEIC-ACID [J].

DOUBLE, JC ;

BROWN, JR .

JOURNAL OF PHARMACY AND PHARMACOLOGY, 1975, 27 (07) :502-507

[3]

JOHNSON RK, 1979, CANCER TREAT REP, V63, P425

[4]

LU K, 1981, P AM ASSOC CANC RES, V22, P351

[5]

LU K, 1980, P AM ASSOC CANC RES, V21, P261

[6] ANTI-TUMOR AGENTS .1. 1,4-BIS[(AMINOALKYL)AMINO]-9,10-ANTHRACENEDIONES [J].

MURDOCK, KC ;

CHILD, RG ;

FABIO, PF ;

ANGIER, RB ;

WALLACE, RE ;

DURR, FE ;

CITARELLA, RV .

JOURNAL OF MEDICINAL CHEMISTRY, 1979, 22 (09) :1024-1030

[7]

MURRAY EF, 1980, ANTHRACYCLINES CURRE, P397

[8]

ROWLAND M, 1976, EFFECT DISEASE STATE

[9]

VONHOFF DD, 1980, CANCER RES, V40, P1516

[10]

WALLACE RE, 1979, CANCER RES, V39, P1570

← 1 2 →